Serious central nervous system side effects of cephalosporins: A national analysis of serious reports registered in the French Pharmacovigilance DatabaseClémence Lacroix, Joëlle Micallef, Farid Kheloufi et al.|Journal of the Neurological Sciences|2019Cited by 60
Artificial Intelligence for Unstructured Healthcare Data: Application to Coding of Patient Reporting of Adverse Drug ReactionsLouis Létinier, Alexandre Pariente, Julien Jouganous et al.|Clinical Pharmacology & Therapeutics|2021Cited by 48
Cannabis for the treatment of amyotrophic lateral sclerosis: What is the patients’ view?Clémence Lacroix, Olivier Blin, Romain Guilhaumou et al.|Revue Neurologique|2023Cited by 32
Serious Neurological Adverse Events of CeftriaxoneClémence Lacroix, Romain Guilhaumou, Annie-Pierre Bera-Jonville et al.|Antibiotics|2021Cited by 29
French organization for the pharmacovigilance of COVID-19 vaccines: A major challengeClémence Lacroix, Joëlle Micallef, A.‐P. Jonville‐Béra et al.|Therapies|2021Cited by 28